90 related articles for article (PubMed ID: 11259538)
1. Probenecid-associated alterations in valproate glucuronide hepatobiliary disposition: mechanistic assessment using mathematical modeling.
Ward ES; Pollack GM; Brouwer KL
J Pharmacol Exp Ther; 2001 Apr; 297(1):141-7. PubMed ID: 11259538
[TBL] [Abstract][Full Text] [Related]
2. Probenecid-associated alterations in valproic acid pharmacokinetics in rats: can in vivo disposition of valproate glucuronide be predicted from in vitro formation data?
Ward ES; Pollack GM; Brouwer KL
Drug Metab Dispos; 2000 Dec; 28(12):1433-9. PubMed ID: 11095580
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary disposition of valproic acid and valproate glucuronide: use of a pharmacokinetic model to examine the rate-limiting steps and potential sites of drug interactions.
Booth CL; Pollack GM; Brouwer KL
Hepatology; 1996 Apr; 23(4):771-80. PubMed ID: 8666331
[TBL] [Abstract][Full Text] [Related]
4. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver.
Booth CL; Brouwer KR; Brouwer KL
Cancer Res; 1998 Aug; 58(16):3641-8. PubMed ID: 9721873
[TBL] [Abstract][Full Text] [Related]
5. Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat.
Pollack GM; Brouwer KL
J Pharmacokinet Biopharm; 1991 Apr; 19(2):189-225. PubMed ID: 2013839
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.
Ueda K; Kato Y; Komatsu K; Sugiyama Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems.
Hoffmaster KA; Zamek-Gliszczynski MJ; Pollack GM; Brouwer KL
J Pharmacol Exp Ther; 2004 Dec; 311(3):1203-10. PubMed ID: 15302892
[TBL] [Abstract][Full Text] [Related]
8. In vitro mechanisms of probenecid-associated alterations in acetaminophen glucuronide hepatic disposition.
Turner KC; Brouwer KL
Drug Metab Dispos; 1997 Sep; 25(9):1017-21. PubMed ID: 9311615
[TBL] [Abstract][Full Text] [Related]
9. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat.
Savina PM; Brouwer KL
Drug Metab Dispos; 1992; 20(4):496-501. PubMed ID: 1356724
[TBL] [Abstract][Full Text] [Related]
10. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats.
Yamamura N; Imura K; Naganuma H; Nishimura K
Drug Metab Dispos; 1999 Jun; 27(6):724-30. PubMed ID: 10348803
[TBL] [Abstract][Full Text] [Related]
11. Protein binding and hepatobiliary distribution of valproic acid and valproate glucuronide in rats.
Brouwer KL; Hall ES; Pollack GM
Biochem Pharmacol; 1993 Feb; 45(3):735-42. PubMed ID: 8442771
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary disposition of rhodamine 123 in isolated perfused rat livers.
Parasrampuria R; Mehvar R
Xenobiotica; 2008 Oct; 38(10):1263-73. PubMed ID: 18798123
[TBL] [Abstract][Full Text] [Related]
13. Hepatic disposition of the acyl glucuronide1-O-gemfibrozil-beta-D-glucuronide: effects of dibromosulfophthalein on membrane transport and aglycone formation.
Sabordo L; Sallustio BC; Evans AM; Nation RL
J Pharmacol Exp Ther; 1999 Feb; 288(2):414-20. PubMed ID: 9918540
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of xenobiotics II: Studies with isolated perfused rat liver.
Higaki K; Ishii M; Esumi H; Kanayama M; Ogawara KI; Kimura T
Xenobiotica; 2003 Nov; 33(11):1097-108. PubMed ID: 14660174
[TBL] [Abstract][Full Text] [Related]
15. Disposition of isosteviol in the rat isolated perfused liver.
Jin H; Wang J; Gerber JP; Davey AK
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):593-7. PubMed ID: 20082626
[TBL] [Abstract][Full Text] [Related]
16. Probenecid-associated alterations in valproic acid pharmacokinetics in rats: can in vivo disposition of valproate glucuronide be predicted from in vitro formation data?
Yeleswaram S
Drug Metab Dispos; 2001 May; 29(5):777-8. PubMed ID: 11374361
[No Abstract] [Full Text] [Related]
17. Application of a loading wash-out method for investigating the hepatocellular efflux of a hepatically-generated metabolite, morphine-3-glucuronide.
Evans AM; O'Brien J; Nation RL
J Pharm Pharmacol; 1999 Nov; 51(11):1289-97. PubMed ID: 10632087
[TBL] [Abstract][Full Text] [Related]
18. Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
Sallustio BC; Fairchild BA; Shanahan K; Evans AM; Nation RL
Drug Metab Dispos; 1996 Sep; 24(9):984-9. PubMed ID: 8886608
[TBL] [Abstract][Full Text] [Related]
19. Effects of dose, flow rate, and bile acid on diclofenac disposition in the perfused rat liver.
Uraki M; Kawase A; Matsushima Y; Iwaki M
Eur J Drug Metab Pharmacokinet; 2016 Jun; 41(3):301-7. PubMed ID: 25656736
[TBL] [Abstract][Full Text] [Related]
20. Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats.
Hu J; Liu X; Xie L; Wang G; Liu H
Xenobiotica; 2007 Jun; 37(6):579-91. PubMed ID: 17614005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
